Skip to main content

Table 3 In vitro antimicrobial susceptibilities of the strain, and interpretation according to Comité d’Antibiogramme de la Société Française de Microbiologie 2015 recommendations, using Pseudomonas aeruginosa ATCC 27853 and Escherichia coli ATCC 25922 as quality control

From: Chryseobacterium gleum in a man with prostatectomy in Senegal: a case report and review of the literature

Antibiotics

MIC

IZD

Breakpointa

S

Categorization

(μg/mL)

(mm)

(μg/mL)

(mm)

Ticarcillin

≥256

0

≤16

≥18

Resistant

Ticarcillin + AC

64

8

≤16

≥18

Resistant

Piperacillin

6

26

≤16

≥18

Susceptible

Ceftazidime

0.75

22

≤8

≥16

Susceptible

Cefotaxime

>32

8

-

-

Resistant

Cefepime

0.125

37

≤8

≥19

Susceptible

Aztreonam

≥256

0

≤1

≥50

Resistant

Imipenem

2

25

≤4

≥20

Susceptible

Meropenem

8

15

≤2

≥18

Resistant

Ciprofloxacin

0.25

30

≤0.5

≥25

Susceptible

Co-trimoxazole

0.094

28

-

-

Susceptible

  1. - cefotaxime breakpoint not given, AC clavulanic acid, IZD inhibition zone diameter, MIC minimum inhibitory concentration, S Susceptibility
  2. aAntimicrobial susceptibilities interpretation was done according to Comité d’Antibiogramme de la Société Française de Microbiologie 2015 recommendations using Pseudomonas species as reference